차바이오텍

Filings by 차바이오텍 span 2 companies, the busiest being 차백신연구소 and 차바이오텍. In total, 8 filings cover trades dated from 28 October 2021 to 30 April 2026.

Market trades split into 2 purchases (€13.8M) and 5 sales (€16.0M). The totals do not cover 5 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and 1 sale.

The newest entry dates from 8 May 2026: an open-market sale of €16.0M, in 차백신연구소. The latest purchase dates back some time: it was published 170 days ago, on 8 May 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.